Clinical Interventions

FDA Approves Expanded Use of Gardasil 9

October 8, 2018

The Food and Drug Administration (FDA) announces it has approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.

UTMB Develops a Universal Vaccine Platform That is Cheaper and Shelf Stable

October 7, 2018

Researchers at the University of Texas Medical Branch at Galveston have developed less expensive way to produce vaccines that cuts the costs of vaccine production and storage by up to 80 percent without decreasing safety or effectiveness. The findings are currently available in EBioMedicine.